Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000022344 | SCV000826231 | uncertain significance | Renal carnitine transport defect | 2022-07-20 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 257 of the SLC22A5 protein (p.Arg257Trp). This variant is present in population databases (rs386134203, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of carnitine deficiency (PMID: 20574985). This variant is also known as c.841C>T (p.Arg281Trp). ClinVar contains an entry for this variant (Variation ID: 25391). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC22A5 protein function. Experimental studies have shown that this missense change affects SLC22A5 function (PMID: 28841266). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Giacomini Lab, |
RCV000022344 | SCV002576669 | uncertain significance | Renal carnitine transport defect | 2022-10-03 | criteria provided, single submitter | research | |
Fulgent Genetics, |
RCV000022344 | SCV002813500 | uncertain significance | Renal carnitine transport defect | 2021-11-21 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000022344 | SCV004201270 | pathogenic | Renal carnitine transport defect | 2024-03-14 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000022344 | SCV001462810 | uncertain significance | Renal carnitine transport defect | 2020-09-16 | no assertion criteria provided | clinical testing |